Skip to main content
. 2022 Dec 26;141(17):2075–2084. doi: 10.1182/blood.2022017118

Figure 2.

Figure 2.

Best reduction in tumor volume per BICR in patients who proceeded to consolidation on protocol. On the basis of sum of products of diameters (SPD) for target lesions. Includes patients with baseline and ≥1 on-study value (before consolidation or subsequent therapy). Negative values indicate reduction from baseline in SPD. Square symbol represents percentage change truncated to 100%. PMR, partial metabolic response.